Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling.
复制标题
血小板释放物通过 VEGF-整合素协同信号促进乳腺癌生长和血管生成
DOI:
10.1038/bjc.2017.214
复制
发表时间:
2017-08-22
影响因子:
8.8
通讯作者:
Li N
中科院分区:
文献类型:
--
作者:
Jiang L;Luan Y;Miao X;Sun C;Li K;Huang Z;Xu D;Zhang M;Kong F;Li N
Background:Selective platelet release of pro-or anti-angiogenic factors distinctly regulated angiogenesis. We hypothesised that selective release of platelet angiogenic factors could differently regulate tumour growth.Methods:Breast cancer cell proliferation, cancer cell-induced endothelial tube formation in vitro, and tumour growth in vivo were studied in the presence of protease-activated receptor 1-stimulated platelet releasate (PAR1-PR; rich in pro-angiogenic factors) or PAR4-PR (rich in anti-angiogenic factors).Results:The PAR1-PR and PAR4-PR supplementation (10%) similarly enhanced cell proliferation of MCF-7 and MDA-MB-231 breast cancer cells. The cancer cells triggered capillary-like tube formation of endothelial cells that was further enhanced by pro-angiogenic factor-rich PAR1-PR. The VEGF, but not SDF-1α, receptor blockade abolished PAR1-PR/PAR4-PR-enhanced cancer cell proliferation. Integrin blockade by RGDS had identical effects as VEGF inhibition. The Src and ERK inhibition diminished, whereas PI3K and PKC blockade abolished platelet releasate-enhanced cancer cell proliferation. Using a model of subcutaneous implantation of MDA-MB-231 cells in nude mice, PAR1-PR enhanced tumour growth more markedly than PAR4-PR, and seemed to achieve the exaggeration by promoting more profound tumour angiogenesis.Conclusions:Platelet releasate increases breast cancer cell proliferation through VEGF–integrin cooperative signalling. Pro-angiogenic factor-rich platelet releasate enhances cancer cell-induced angiogenesis more markedly, and thus exaggerates tumour growth in vivo.
登录
查看更多内容
影响因子:
28.2
作者:
Kuznetsov HS;Marsh T;Markens BA;Castaño Z;Greene-Colozzi A;Hay SA;Brown VE;Richardson AL;Signoretti S;Battinelli EM;McAllister SS
通讯作者:
McAllister SS
影响因子:
4.8
作者:
Vlahakis, Nicholas E.;Young, Bradford A.;Sheppard, Dean
通讯作者:
Sheppard, Dean
DOI:
10.1158/1078-0432.ccr-14-0870
发表时间:
2015-02-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Bottsford-Miller J;Choi HJ;Dalton HJ;Stone RL;Cho MS;Haemmerle M;Nick AM;Pradeep S;Zand B;Previs RA;Pecot CV;Crane EK;Hu W;Lutgendorf SK;Afshar-Kharghan V;Sood AK
通讯作者:
Sood AK
DOI:
10.1038/nrc3004
发表时间:
2011-03
期刊:
Nature reviews. Cancer
影响因子:
--
作者:
Gay LJ;Felding-Habermann B
通讯作者:
Felding-Habermann B
影响因子:
50.3
作者:
Labelle M;Begum S;Hynes RO
通讯作者:
Hynes RO